An overview of the evolution of EV71 vaccine.
- Author:
Ming LI
1
;
Yi YIN
;
Jintao LI
Author Information
1. Student Brigade, Third Military Medical University, Chongqing 400038, China.
- Publication Type:Journal Article
- MeSH:
Enterovirus A, Human;
immunology;
Hand, Foot and Mouth Disease;
immunology;
prevention & control;
Humans;
Vaccines, Attenuated;
immunology;
Vaccines, DNA;
immunology;
Vaccines, Inactivated;
immunology;
Vaccines, Synthetic;
immunology;
Viral Vaccines;
immunology
- From:
Journal of Biomedical Engineering
2010;27(4):933-936
- CountryChina
- Language:Chinese
-
Abstract:
EV71 infection has become a serious public health threat especially among young children. Yet, at present, no specific antiviral drug against EV71 infection is available. A number of scientists are studying various kinds of vaccines, including inactivated vaccine, virus-like particle vaccine, DNA vaccine, synthetic peptide vaccines, and transgenic oral vaccine. This article reviews the recent advancement in the design of various kinds of vaccine against EV71 as well as their prospective usefulness, effectiveness, weakness and developments in the foreground.
